Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics
UNCY Price/Volume Stats
| Current price | $0.68 | 52-week high | $1.82 |
| Prev. close | $0.71 | 52-week low | $0.20 |
| Day low | $0.68 | Volume | 1,338,100 |
| Day high | $0.74 | Avg. volume | 1,247,256 |
| 50-day MA | $0.56 | Dividend yield | N/A |
| 200-day MA | $0.70 | Market Cap | 71.00M |
UNCY Stock Price Chart Interactive Chart >
Unicycive Therapeutics, Inc., (UNCY) Company Bio
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
UNCY Price Returns
| 1-mo | 28.84% |
| 3-mo | 47.83% |
| 6-mo | -0.40% |
| 1-year | 17.24% |
| 3-year | -67.15% |
| 5-year | N/A |
| YTD | -21.63% |
| 2023 | 60.69% |
| 2022 | -73.79% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...